Literature DB >> 18242454

Separate and additive mydriatic effects of lidocaine hydrochloride, phenylephrine, and cyclopentolate after intracameral injection.

Björn Lundberg1, Anders Behndig.   

Abstract

PURPOSE: To assess the separate mydriatic effect of lidocaine hydrochloride (Xylocaine), cyclopentolate, and phenylephrine after intracameral injection and evaluate whether intracameral Xylocaine and phenylephrine without cyclopentolate provide sufficient pupil dilation for cataract surgery.
SETTING: Department of Clinical Science/Ophthalmology, Umeå University Hospital, Umeå, Sweden.
METHODS: This prospective randomized double-masked study included 56 patients with age-related cataract scheduled for unilateral phacoemulsification. In 16 patients, Xylocaine 1%, phenylephrine 1.5%, and cyclopentolate 0.1% were injected one after the other. Phenylephrine and cyclopentolate were randomized to switch in order, creating 2 study groups. An additional 40 patients were randomized to receive intracameral Xylocaine 1%, phenylephrine 1.5%, and cyclopentolate 0.1% or intracameral Xylocaine 1% and phenylephrine 1.5% only.
RESULTS: Xylocaine alone caused significant pupil dilation (mean 4.9 +/- 0.6 mm). In the group in which cyclopentolate was injected next, the pupil size increased 1.3 +/- 0.6 mm (P<.001). When phenylephrine was added, the pupil increased an additional 0.7 +/- 0.4 mm (P = .003). In the second group, in which phenylephrine was the second injection, the pupil size increased 2.1 +/- 0.5 mm (P<.001). When cyclopentolate was added, no significant change in size occurred. No statistically significant differences in pupil size were observed between the 40 patients who were given intracameral mydriatics with or without cyclopentolate.
CONCLUSIONS: Xylocaine plus phenylephrine injected intracamerally gave adequate intraoperative pupil dilation in routine phacoemulsification surgery. Cyclopentolate administrated intracamerally had no immediate additive mydriatic effect to intracameral Xylocaine combined with phenylephrine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242454     DOI: 10.1016/j.jcrs.2007.09.036

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  5 in total

1.  Analysis of pupil size by repeat dilation at shrinkage stage.

Authors:  Weili Zhang; Yanjiang Guo; Yile Chen; Wencan Wu; Jinying Li
Journal:  Int Ophthalmol       Date:  2022-08-10       Impact factor: 2.029

Review 2.  Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.

Authors:  Seanna R Grob; Luis A Gonzalez-Gonzalez; Mary K Daly
Journal:  Clin Ophthalmol       Date:  2014-07-03

3.  Pupil Dilation with Intracameral Epinephrine Hydrochloride during Phacoemulsification and Intraocular Lens Implantation.

Authors:  A-Yong Yu; Hua Guo; Qin-Mei Wang; Fang-Jun Bao; Jing-Hai Huang
Journal:  J Ophthalmol       Date:  2016-01-20       Impact factor: 1.909

4.  Pharmacologic interventions for mydriasis in cataract surgery.

Authors:  Mustafa Iftikhar; Samuel A Abariga; Barbara S Hawkins; Sidra Zafar; Tahreem A Mir; Henry Jampel; Fasika A Woreta
Journal:  Cochrane Database Syst Rev       Date:  2021-05-27

Review 5.  Patient considerations in cataract surgery - the role of combined therapy using phenylephrine and ketorolac.

Authors:  Roberto Gonzalez-Salinas; Adriano Guarnieri; María Concepción Guirao Navarro; Manuel Saenz-de-Viteri
Journal:  Patient Prefer Adherence       Date:  2016-09-15       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.